Takeda Pharmaceutical Company Limited
4502
Ранг среди акций
#375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Цена акции
$40.45
Рыночная капитализация
$64.36B
Изменение (1 день)
1.19%
Изменение (1 год)
43.11%
Страна
JP
Торговля Takeda Pharmaceutical Company Limited (4502)
Категория
Healthcare
Коэффициент P/B для Takeda Pharmaceutical Company Limited (4502)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Takeda Pharmaceutical Company Limited, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Takeda Pharmaceutical Company Limited с 2026 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
CH
|
|
| 5.041 | - |
IN
|
|
| - | - |
CN
|
